Our data support a clinically relevant role of hepatic transporters in darunavir pharmacokinetics. |
We successfully approximated the increase in darunavir exposure mediated by ritonavir co-administration and the decrease in darunavir exposure during pregnancy, using physiologically based pharmacokinetic modelling. |